Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma

NCT01359956 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

269

Enrollment

OTHER

Sponsor class

Conditions

Malignant Melanoma
Recurrent Melanoma

Interventions

DRUG: Dacarbazine
DRUG: Fotemustine
DRUG: Interferon Alfa-2b

Sponsor

National Cancer Institute, Naples